Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 3, 2025 • 5:01 PM ET

Date/Time Source News Release
05/29/2025 08:00 AM EDT PR Newswire Intensity Therapeutics, Inc.'s Phase 3 INVINCIBLE-3 Sarcoma Study Selected for Presentation at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
05/28/2025 08:00 AM EDT PR Newswire Intensity Therapeutics, Inc. to Collaborate with Author, Model, Executive Producer, Speaker and Breast Cancer Survivor Christine Handy to Raise Patient Awareness of Early-Stage Breast Cancer Treatment Options on the Horizon
05/13/2025 04:06 PM EDT PR Newswire Intensity Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
04/25/2025 08:00 AM EDT PR Newswire Intensity Therapeutics, Inc. Announces $2.35 Million Public Offering
03/13/2025 04:07 PM EDT PR Newswire Intensity Therapeutics Reports 2024 Year End Financial Results and Provides Corporate Update
01/28/2025 08:00 AM EST PR Newswire Drug Monitoring Committee Authorizes Continuation of Intensity Therapeutics' Ongoing Global Randomized Phase 3 Sarcoma Trial ("INVINCIBLE-3 Study") Following Periodic Review
01/10/2025 08:00 AM EST PR Newswire Intensity Therapeutics Provides Business Update Highlighting Key Achievements with Lead Drug Candidate INT230-6
11/21/2024 08:00 AM EST PR Newswire Intensity Therapeutics, Inc. Announces Pricing of $3 Million Registered Direct Offering and Concurrent Private Placement
11/13/2024 04:06 PM EST PR Newswire Intensity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
11/08/2024 08:01 AM EST PR Newswire Intensity Therapeutics Selected for Oral Podium Presentation in a Late-Breaking Session at the 2024 Annual Connective Tissue Oncology Society (Sarcomas) Meeting
Page

Additional News

As of June 3, 2025 • 5:01 PM ET

Date/Time Source News Release
05/14/2025 11:32 AM EDT SeekingAlpha Intensity Therapeutics GAAP EPS of -$0.22
05/08/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 8th, 2025
05/08/2025 05:31 AM EDT US Earnings Reports Expected earnings - Intensity Therapeutics Inc.
04/25/2025 09:14 AM EDT SeekingAlpha Intensity Therapeutics plunges on $2.35M public offering
04/21/2025 09:40 AM EDT Zacks Is Cencora, Inc. (COR) Outperforming Other Medical Stocks This Year?
04/03/2025 09:40 AM EDT Zacks Has Cencora, Inc. (COR) Outpaced Other Medical Stocks This Year?
03/13/2025 05:05 PM EDT SeekingAlpha Intensity Therapeutics GAAP EPS of -$1.17 in-line
03/13/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, March 13th, 2025
03/13/2025 05:31 AM EDT US Earnings Reports Expected earnings - Intensity Therapeutics Inc.
12/13/2024 04:13 PM EST SeekingAlpha Intensity Therapeutics files to sell 1.24M shares of common stocks by selling shareholders
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.